Magnetar Financial’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Sell
553,895
-96,105
-15% -$96.4K 0.01% 525
2026
Q1
$96.1K Hold
650,000
﹤0.01% 1016
2025
Q4
$183K Hold
650,000
﹤0.01% 811
2025
Q3
$189K Hold
650,000
﹤0.01% 780
2025
Q2
$188K Buy
+650,000
New +$134K ﹤0.01% 806

Other funds holding TDACW

Magnetar Financial's TDACW Position: Q2 2026 in Review

Magnetar Financial reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 15% in Q2 2026, selling an estimated $96.4K and leaving 553,895 shares worth $731K. The position accounts for 0.01% of the portfolio, ranked #525.

Magnetar Financial first reported a position in TDACW in Q2 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Magnetar Financial held 553,895 shares of Translational Development Acquisition Corp Warrants worth $731K as of Q2 2026.
  • Magnetar Financial sold 96,105 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $96.4K.
  • Translational Development Acquisition Corp Warrants made up 0.01% of Magnetar Financial's portfolio in Q2 2026, its #525 holding.
  • Magnetar Financial first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.